Although Rocket Lab posted strong Q4 sales, its lackluster Q1 guidance raised alarm about valuation risks for RKLB stock.

End-to-end space company Rocket Lab USA Inc (RKLB) received several price target cuts from Wall Street analysts following its ...

Murielle Baker; Senior Communications Manager; Rocket Lab USA Inc. Peter Beck; Chairman of the Board, President, Chief Executive Officer, Founder; Rocket Lab USA Inc ...

Rocket Lab (NASDAQ: RKLB) stock got thrown for a loop Friday morning, first crashing more than 18% in response to a ...

After yesterday’s tariff-induced sell-off, stocks have made their way into positive territory. Now that the S&P 500 has ...

Roth MKM lowered the firm’s price target on Rocket Lab (RKLB) to $25 from $30 and keeps a Buy rating on the shares. The company reported Q4 ...

Space launch provider Rocket Lab USA ( RKLB -6.68%) reported mixed fourth-quarter earnings on Thursday, Feb. 27. Revenue in ...

A lunar lander made by Intuitive Machines lifted off from the Kennedy Space Center in Florida aboard a SpaceX Falcon 9 rocket ...

Rocket Lab faces short-term risk with recent sell-offs and a guidance miss. Long-term investors may find value, but ...

At this time, I would like to welcome everyone to Rocket Lab’s Fourth Quarter 2024 Financial Results Update and Conference Call. All lines have been placed on mute to prevent any background noise.

Reports Q4 revenue $132.39M, consensus $130.57M. Rocket Lab (RKLB) founder and CEO, Sir Peter Beck, said: “2024 was a record-setting year for ...

CRANBURY, N.J. — CRANBURY, N.J. — Rocket Pharmaceuticals Inc. (RCKT) on Thursday reported a loss of $60.3 million in its fourth quarter. The Cranbury, New Jersey-based company said it had a loss of 62 ...